Precision Dose Revenue and Competitors

South Beloit, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Precision Dose's estimated annual revenue is currently $13.9M per year.(i)
  • Precision Dose's estimated revenue per employee is $201,000

Employee Data

  • Precision Dose has 69 Employees.(i)
  • Precision Dose grew their employee count by 6% last year.

Precision Dose's People

NameTitleEmail/Phone
1
VP FinanceReveal Email/Phone
2
VP ProcurementReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
VP Product DevelopmentReveal Email/Phone
5
Director Human ResourcesReveal Email/Phone
6
IT ManagerReveal Email/Phone
7
Quality Control ManagerReveal Email/Phone
8
Warehouse ManagerReveal Email/Phone
9
Human Resources ManagerReveal Email/Phone
10
Sales and Marketing AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$6.6M33-8%N/AN/A
#8
$13.5M67-3%N/AN/A
#9
$186.3M92719%N/AN/A
#10
$4.4M22-4%N/AN/A
Add Company

What Is Precision Dose?

PrecisionDose is a FDA registered producer of unit-dose pharmaceutical products. Pioneers of unit dosing, PrecisionDose provides a wide range of oral liquid medications in both unit dose cups and pre-filled oral syringes. Our management team consists of highly specialized professionals with decades of experience in pharmaceutical manufacturing, repackaging and distribution. From operations, to quality/compliance to marketing, the PrecisionDose team is committed to meeting your unit dose needs. The PrecisionDose product line includes a wide variety of solution, syrup and suspension oral medications in unit-dose cup or oral syringe form.

keywords:Healthcare,Household & Personal Products,Personal Products,Pharmaceuticals

N/A

Total Funding

69

Number of Employees

$13.9M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Precision Dose News

2022-04-20 - mRNA COVID-19 Vaccine Booster for Children Aged 5+ Authorization Pending

Announced on April 26, 2022, the FDA submission included data from the Phase 2/3 clinical trial in 141 children who received a booster dose...

2022-04-17 - Black Diamond trims 30% of workforce and cuts precision ...

... run at a precision oncology med after getting a glimpse of the rocky ... the recommended phase 2 dose before starting a mid-stage trial.

2022-04-17 - WITH RECORD CUSTOMER GROWTH, GENXYS SUPPORTS RIGHT DRUG DOSE NOW ACT TO REDUCE ADVERSE DRUG REACTIONS THROUGH PRECISION MEDICINE

WITH RECORD CUSTOMER GROWTH, GENXYS SUPPORTS RIGHT DRUG DOSE NOW ACT TO REDUCE ADVERSE DRUG REACTIONS THROUGH PRECISION MEDICINE.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.5M7410%N/A
#2
$16.5M75N/AN/A
#3
$25.4M940%N/A
#4
$48.8M1536%N/A
#5
$23.4M2135%N/A